Stephan E Baldus

Author PubWeight™ 69.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat Immunol 2011 2.51
2 Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? J Surg Oncol 2006 1.70
3 Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg 2005 1.60
4 High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF. Neoplasia 2008 1.56
5 Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer. Ann Surg 2008 1.55
6 Reproducibility of immunohistochemical scoring for epidermal growth factor receptor expression in non-small cell lung cancer: round robin test. Arch Pathol Lab Med 2012 1.53
7 Prognostic significance of a new grading system of lymph node morphology after neoadjuvant radiochemotherapy for esophageal cancer. Ann Thorac Surg 2011 1.50
8 The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation. Oncol Rep 2008 1.34
9 Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis. Gastroenterology 2005 1.32
10 Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS One 2013 1.27
11 Depletion of neutrophil extracellular traps in vivo results in hypersusceptibility to polymicrobial sepsis in mice. Crit Care 2012 1.16
12 High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer. Clin Cancer Res 2004 1.14
13 Artificial neural network for prediction of lymph node metastases in gastric cancer: a phase II diagnostic study. Ann Surg Oncol 2004 1.13
14 Mutations in the mitochondrial DNA D-Loop region occur frequently in adenocarcinoma in Barrett's esophagus. Oncogene 2002 1.09
15 Prognostic impact of protein overexpression of the proto-oncogene PIM-1 in gastric cancer. Anticancer Res 2009 1.04
16 Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest 2003 1.04
17 [18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer. Ann Surg 2009 1.02
18 Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression. Nucl Med Commun 2010 1.01
19 Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas. J Pathol 2004 1.01
20 Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer. J Am Coll Surg 2005 1.00
21 Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis. Anticancer Res 2010 0.94
22 Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy. Clin Cancer Res 2007 0.94
23 High EpCAM expression is linked to proliferation and lauren classification in gastric cancer. BMC Res Notes 2013 0.93
24 Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma. Ann Surg Oncol 2008 0.92
25 Increased EpCAM expression in malignant insulinoma: potential clinical implications. Eur J Endocrinol 2010 0.92
26 Differential expression proteomics of human colorectal cancer based on a syngeneic cellular model for the progression of adenoma to carcinoma. Proteomics 2010 0.92
27 Down-regulation of CDH1 is associated with expression of SNAI1 in colorectal adenomas. PLoS One 2012 0.91
28 SMAD4 mediates mesenchymal-epithelial reversion in SW480 colon carcinoma cells. Anticancer Res 2010 0.91
29 High expression of heparanase is significantly associated with dedifferentiation and lymph node metastasis in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA and via HIF1a to HB-EGF and bFGF. J Gastrointest Surg 2008 0.90
30 Differences between biopsy- or specimen-related Laurén and World Health Organization classification in gastric cancer. World J Surg 2001 0.90
31 Lymph node staging of esophageal squamous cell carcinoma in patients with and without neoadjuvant radiochemotherapy: histomorphologic analysis. World J Surg 2002 0.89
32 Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater. Oncol Rep 2006 0.89
33 Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes. Cancer 2004 0.88
34 Down-regulation of Gadd45 expression is associated with tumor differentiation in non-small cell lung cancer. Anticancer Res 2006 0.88
35 Extracapsular lymph node spread: a new prognostic factor in gastric cancer. Cancer 2010 0.87
36 Transmembrane and secreted MUC1 probes show trafficking-dependent changes in O-glycan core profiles. Glycobiology 2005 0.87
37 Extracapsular lymph node involvement differs between squamous cell and adenocarcinoma of the esophagus. Ann Surg Oncol 2008 0.87
38 Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases. Oncol Rep 2008 0.86
39 Neoadjuvant chemoradiotherapy for esophageal cancer: impact on extracapsular lymph node involvement. World J Gastroenterol 2010 0.86
40 Histological grading in gastric cancer by Ming classification: correlation with histopathological subtypes, metastasis, and prognosis. World J Surg 2005 0.85
41 Splenic rupture: an unusual complication of colonoscopy: case report and review of the literature. Surg Laparosc Endosc Percutan Tech 2006 0.85
42 Topographical distribution of lymph node metastasis in adenocarcinoma of the gastroesophageal junction. Hepatogastroenterology 2002 0.85
43 Clinical significance of nm23 gene expression in gastric cancer. Anticancer Res 2007 0.85
44 KRAS p.G13D mutations are associated with sensitivity to anti-EGFR antibody treatment in colorectal cancer cell lines. J Cancer Res Clin Oncol 2012 0.84
45 E2 and the co-activator p300 can cooperate in activation of the human papillomavirus type 16 early promoter. Virology 2008 0.84
46 Failure in downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancer. Pharmacogenomics 2008 0.84
47 Esophageal cancer proliferation is mediated by cytochrome P450 2C9 (CYP2C9). Prostaglandins Other Lipid Mediat 2010 0.84
48 Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer. Ann Surg Oncol 2010 0.83
49 High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer. Clin Cancer Res 2005 0.83
50 COX-2 mRNA expression is significantly increased in acid-exposed compared to nonexposed squamous epithelium in gastroesophageal reflux disease. J Gastrointest Surg 2007 0.83
51 Rapid immunohistochemical detection of tumor cells in gastric carcinoma. Oncol Rep 2006 0.83
52 Snail1 expression in colorectal cancer and its correlation with clinical and pathological parameters. BMC Cancer 2013 0.83
53 Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis. Anticancer Res 2008 0.82
54 Sequence-variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differential B lymphocyte responses. Glycobiology 2005 0.82
55 Methylenetetrahydrofolate reductase C677T polymorphism and risk of adenocarcinoma of the upper gastrointestinal tract. Scand J Gastroenterol 2005 0.82
56 Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer. Anticancer Res 2009 0.81
57 Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer. Ann Surg Oncol 2006 0.80
58 Differential c-erbB-1 and c-erbB-2 mRNA expression in cancer of the pancreas compared with cancer of the papilla of Vater. World J Gastroenterol 2006 0.80
59 Fatal outcome despite full lympho-hematopoietic reconstitution after allogeneic stem cell transplantation in atypical ataxia telangiectasia. J Clin Immunol 2012 0.80
60 Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis. Am J Pathol 2003 0.79
61 Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer. Oncol Rep 2005 0.79
62 Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer. Pancreas 2008 0.79
63 Localization of isolated lymph node metastases in esophageal cancer--does it influence the sentinel node concept? Hepatogastroenterology 2007 0.78
64 PCR-screening of human esophageal and bronchial cancers reveals absence of adenoviral DNA sequences. Virus Res 2004 0.78
65 Presence of Epstein-Barr virus in esophageal cancer is restricted to tumor infiltrating lymphocytes. Med Microbiol Immunol 2005 0.78
66 p16, cyclin D1 and Rb expression in colorectal carcinomas: Correlations with clinico-pathological parameters and prognosis. Mol Med Rep 2011 0.78
67 TaqMan low-density arrays and analysis by artificial neuronal networks predict response to neoadjuvant chemoradiation in esophageal cancer. Pharmacogenomics 2010 0.78
68 Lymph node revealing solution in gastric carcinoma does not provide upstaging of the N-status. Oncol Rep 2005 0.77
69 Recurrent Mastitis after Core Needle Biopsy: Case Report of an Unusual Complication after Core Needle Biopsy of a Phyllodes Tumor. Breast Care (Basel) 2012 0.77
70 Modulation of MUC1 and blood group antigen expression in gastric adenocarcinoma cells by cytokines. Cytokine 2003 0.77
71 Characterization of squamous cell cancers of the vulvar anterior fourchette by human papillomavirus, p16INK4a, and p53. J Low Genit Tract Dis 2013 0.77
72 Treatment of chemotherapy resistant ovarian cancer with a MDR1 targeted oncolytic adenovirus. Gynecol Oncol 2011 0.77
73 Unusual histological findings after partial pancreaticoduodenectomy including benign multicystic mesothelioma, adenomyoma of the ampulla of Vater, and undifferentiated carcinoma, sarcomatoid variant: a case series. J Med Case Rep 2010 0.75
74 Altered apoptosis and cell cycling of mast cells in bone marrow lesions of patients with systemic mastocytosis. Haematologica 2004 0.75
75 HIF-1alpha mRNA is not associated with histopathological regression following neoadjuvant chemoradiation in esophageal cancer. Anticancer Res 2007 0.75